First Time Loading...

ImExHS Ltd
ASX:IME

Watchlist Manager
ImExHS Ltd Logo
ImExHS Ltd
ASX:IME
Watchlist
Price: 0.58 AUD 3.57% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

IME doesn't have a meaningful market cap.

ImExHS Ltd. is a technology company. [ Read More ]

The intrinsic value of one IME stock under the Base Case scenario is 1.06 AUD. Compared to the current market price of 0.58 AUD, ImExHS Ltd is Undervalued by 45%.

Key Points:
IME Intrinsic Value
Base Case
1.06 AUD
Undervaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
ImExHS Ltd

Backtest IME Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IME stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of ImExHS Ltd's business.

What risks and challenges
does ImExHS Ltd face in the near future?

Summarize the latest earnings report
of ImExHS Ltd.

Provide P/E
for ImExHS Ltd and its competitors.

Financials

Balance Sheet Decomposition
ImExHS Ltd

Current Assets 8.9m
Cash & Short-Term Investments 2.4m
Receivables 6.2m
Other Current Assets 379.2k
Non-Current Assets 13.7m
PP&E 4.6m
Intangibles 8.6m
Other Non-Current Assets 512.4k
Current Liabilities 6.4m
Accounts Payable 2.4m
Accrued Liabilities 2m
Short-Term Debt 8k
Other Current Liabilities 1.9m
Non-Current Liabilities 297k
Long-Term Debt 215.8k
Other Non-Current Liabilities 81.3k
Efficiency

Earnings Waterfall
ImExHS Ltd

Revenue
19.7m AUD
Cost of Revenue
-13.3m AUD
Gross Profit
6.4m AUD
Operating Expenses
-9m AUD
Operating Income
-2.6m AUD
Other Expenses
-1.6m AUD
Net Income
-4.2m AUD

Free Cash Flow Analysis
ImExHS Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

IME Profitability Score
Profitability Due Diligence

ImExHS Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing
Positive 1-Year Revenue Growth
25/100
Profitability
Score

ImExHS Ltd's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

IME Solvency Score
Solvency Due Diligence

ImExHS Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
55/100
Solvency
Score

ImExHS Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IME Price Targets Summary
ImExHS Ltd

Wall Street analysts forecast IME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IME is 1.53 AUD with a low forecast of 1.52 AUD and a high forecast of 1.58 AUD.

Lowest
Price Target
1.52 AUD
161% Upside
Average
Price Target
1.53 AUD
164% Upside
Highest
Price Target
1.58 AUD
172% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

IME Price
ImExHS Ltd

1M 1M
-6%
6M 6M
-3%
1Y 1Y
+16%
3Y 3Y
-74%
5Y 5Y
-52%
10Y 10Y
-100%
Annual Price Range
0.58
52w Low
0.5
52w High
0.7
Price Metrics
Average Annual Return -11.53%
Standard Deviation of Annual Returns 50.51%
Max Drawdown -89%
Shares Statistics
Market Capitalization 24.7m AUD
Shares Outstanding 44 999 200
Percentage of Shares Shorted
N/A

IME Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

ImExHS Ltd Logo
ImExHS Ltd

Country

Australia

Industry

Health Care

Market Cap

24.7m AUD

Dividend Yield

0%

Description

ImExHS Ltd. is a technology company. The company is headquartered in Mascot, New South Wales. The company went IPO on 2005-12-14. The firm offers imaging solutions through its AQUILA branded suite for next generation picture archiving and communications system (PACS) and integrated medical imaging systems, including a radiology information system (RIS), a cardiology information system (CIS) and an anatomical pathology laboratory information system (APLIS). The RIS, CIS and APLIS combine a workflow management system with a patient data and image distribution system, and the PACS allows a healthcare organization to capture, store, view and share radiology images. ALULA is a cloud-based solution, which enables to operate, monitor, control and automate the day-to-day pathology process inside the center. The Company’s subsidiaries include Imaging Experts and Healthcare Services Pty Ltd, Imaging Experts and Healthcare Services S.A.S. and IMEXHS Corp.

Contact

NEW SOUTH WALES
Mascot
122 O'Riordan St
http://omnimarkettide.com/

IPO

2005-12-14

Employees

-

Officers

Co-Founder, CEO, MD & Director
Dr. German Arango
CFO & Company Secretary
Ms. Reena Minhas
Co-Founder & Chief Medical Officer
Dr. Jorge H-Marin Munoz
Co-Founder & Strategic Accounts Manager
Mr. Andres Vanegas
Co-Founder & CTO
Mr. Alexander Sanz
Chief Operating Officer
Mr. Orlando Joven
Show More
Head of Sales
Mr. Juan Sebastian Bonnet
Head of Growth
Mr. Benjamin Brinquis
Show Less

See Also

Discover More
What is the Intrinsic Value of one IME stock?

The intrinsic value of one IME stock under the Base Case scenario is 1.06 AUD.

Is IME stock undervalued or overvalued?

Compared to the current market price of 0.58 AUD, ImExHS Ltd is Undervalued by 45%.